Skip to main content

Evoke Pharma Inc

EVOKDelisted Dec 17, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001403708

Evoke Pharma Inc was delisted on Dec 17, 2025; its insiders filed their last Form 4 on Dec 19, 2025; 15 institutions reported holding it in 13F filings for Q3 2025, worth $2.94M in total; no superinvestor held it.

Q3 2025 vs. Q2 2025

How the institutions holding Evoke Pharma Inc changed between Q2 2025 and Q3 2025.

All holders in Q3 2025All holders in Q2 2025

13F holders of EVOK: Q2 2025 compared with Q3 2025
MeasureQ2 2025Q3 2025Change
Holders1015+5
Shares232.0K590.7K+358.7K (+154.6%)
Value$603.6K$2.94M+$2.33M (+386.6%)

New holders (7)

Institutions that held Evoke Pharma Inc at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to EVOK in Q3 2025
InstitutionSharesValue% of portfolio
National Wealth Management Group, LLC80,130$398.2K0.15%
DRW Securities, LLC23,742$118.0K0.01%
Vanguard Group Inc18,759$93.2K0.00%
Two Sigma Securities, LLC10,437$51.9K0.01%
Advisor Group Holdings, Inc.3,010$16.4K0.00%
Northwestern Mutual Wealth Management Co272$1.35K0.00%
Royal Bank of Canada190$1.00K0.00%

Sold out (2)

Institutions that held Evoke Pharma Inc at the end of Q2 2025 and filed for Q3 2025 without it.

Institutions that sold out of EVOK in Q3 2025
InstitutionShares, Q2 2025Value, Q2 2025
Citadel Advisors LLC12,542$33.0K
FMR LLC301$792